HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

Table 3 Association of Statin use with Patient Survival and Graft Survival

	Patient Survival	Graft Survival
Crude	0.99 (0.72,1.37)	0.97 (0.76,1.24)
Adjusted ¹	0.86 (0.60,1.22)	0.93 (0.71,1.22)
Weighted propensity ¹	0.86 (0.68,1.09)	0.98 (0.82,1.18)
Continuous propensity score ²	0.82 (0.58,1.25)	0.90(0.70,1.17)
Quintiles of Propensity score ²	0.81 (0.57,1.15)	0.89 (0.68,1.16)

1 age, sex, race BMI, BMI2, donor type, previous transplant, CMV IgG positivity, tolerance protocol, creatinine at twelve months, myocardial infarction, severe liver disease
2. Previous transplant, creatinine at twelve months, myocardial infarction, severe liver disease

ISSN: 1471-2369